Ibtrozi™ (taletrectinib)
for Lung Cancer

Ibtrozi (taletrectinib) is used to treat ROS1-positive non-small cell lung cancer that has spread in adults. It is a kinase inhibitor that blocks overactive ROS1 and TRK proteins caused by gene fusions or mutations. These proteins drive cancer cell growth by sending abnormal signals. By inhibiting them, Ibtrozi helps slow or stop tumor growth.

Heart
Other top medicines used to treat Lung Cancer